Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Fax+1 507-284-0161
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ajit Goenka, MD is a board certified nuclear medicine physician in Rochester, Minnesota. He is currently licensed to practice medicine in Minnesota, Wisconsin, and Ohio.
Education & Training
Cleveland Clinic FoundationFellowship, Nuclear Radiology, 2013 - 2014
Seth G.S. Medical CollegeClass of 2007
Certifications & Licensure
OH State Medical License 2011 - 2027- OH State Medical License 2014 - 2027
MN State Medical License 2015 - 2025
WI State Medical License 2015 - 2025
American Board of Nuclear Medicine Nuclear Medicine
American Board of Radiology Diagnostic Radiology
Publications & Presentations
PubMed
- 1 citationsAdvancements in early detection of pancreatic cancer: the role of artificial intelligence and novel imaging techniques.Chenchan Huang, Yiqiu Shen, Samuel J Galgano, Ajit H Goenka, Elizabeth M Hecht
Abdominal Radiology. 2025-04-01 - Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma.Jordan M Cloyd, Angela Sarna, Matthew J Arango, Susan E Bates, Manoop S Bhutani
JAMA Surgery. 2025-02-01 - 2 citationsSNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET.Thomas A Hope, Jeremie Calais, Ajit H Goenka, Uwe Haberkorn, Mark Konijnenberg
Journal of Nuclear Medicine. 2025-01-03
Press Mentions
Beyond the Code: Advancing Early Pancreatic Cancer DiagnosesApril 15th, 2025- Mayo Clinic to Lead New Radiotracer Trial for Detecting Pancreatic CancerJanuary 30th, 2023
- New Study in JNCCN Suggests Way to Predict Outcomes with High Accuracy Prior to Surgery for Pancreatic Cancer PatientsSeptember 8th, 2022
- Join now to see all
Grant Support
- Quantitative In Vivo 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 PET Imaging of Cancer-Associated Fibroblasts (CAFs) in Pancreatic Ductal Adenocarcinoma (PDA)MAYO CLINIC ROCHESTER2022–2027
- Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid BiopsyFRED HUTCHINSON CANCER CENTER2021–2026
